Cantor Fitzgerald Upgrades Omeros to Overweight, Announces $22 Price Target

9/22/2026
Impact: 75
Healthcare

Cantor Fitzgerald analyst Olivia Brayer Saunders has upgraded Omeros (NASDAQ: OMER) from a Neutral to an Overweight rating. The firm has set a price target of $22 for the stock.

AI summary, not financial advice

Share: